[1] |
Oselin K, Girard N, Lepik K, et al.
Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience[J]. J Thorac DisJ Thorac Dis, 2019, 11(2): 456-464.
doi: 10.21037/jtd.2018.12.123 |
[2] |
Marx A, Chan JKC, Coindre JM, et al.
The 2015 World Health Organization classification of tumors of the thymus: continuity and changes[J]. J Thorac OncolJ Thorac Oncol, 2015, 10(10): 1383-1395.
doi: 10.1097/JTO.0000000000000654 |
[3] |
Ishibashi M, Tanabe Y, Yunaga H, et al.
Usefulness of preoperative 18F-FDG PET/CT for patients with thymic epithelial tumors[J]. Yonago Acta MedYonago Acta Med, 2019, 62(1): 146-152.
doi: 10.33160/yam.2019.03.020 |
[4] |
高珂梦, 丁重阳, 孙晋, 等.
原发性肺黏膜相关淋巴组织淋巴瘤的18F-FDG PET/CT影像学表现[J]. 国际放射医学核医学杂志国际放射医学核医学杂志, 2019, 43(2): 140-144.
doi: 10.3760/cma.j.issn.1673-4114.2019.02.008 Gao KM, Ding CY, Sun J, et al. 18F-FDG PET/CT manifestation of primary pulmonary mucosa-associated lymphoid tissue lymphoma[J]. Int J Radiat Med Nucl MedInt J Radiat Med Nucl Med, 2019, 43(2): 140-144. doi: 10.3760/cma.j.issn.1673-4114.2019.02.008 |
[5] |
丁辉, 胡传贤, 黄苏, 等.
基于CT和18F-FDG PET/CT的肺癌风险预测模型对肺结节恶性风险的验证研究[J]. 国际放射医学核医学杂志国际放射医学核医学杂志, 2019, 43(1): 17-21.
doi: 10.3760/cma.j.issn.1673-4114.2019.01.004 Ding H, Hu CX, Huang S, et al. Verification of malignant risk of pulmonary nodules based on CT and 18F-FDG PET/CT prediction model[J]. Int J Radiat Med Nucl MedInt J Radiat Med Nucl Med, 2019, 43(1): 17-21. doi: 10.3760/cma.j.issn.1673-4114.2019.01.004 |
[6] |
Lococo F.
The role of 18F-FDG PET/CT scan in predicting histological type of thymic epithelial tumors: indications and practical clinical considerations[J]. Thorac Cardiovasc SurgThorac Cardiovasc Surg, 2018, 66(4): 350-351.
doi: 10.1055/s-0037-1604209 |
[7] |
Lee HS, Oh JS, Park YS, et al.
Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via 18F-FDG PET/CT[J]. Ann Nucl MedAnn Nucl Med, 2016, 30(4): 309-319.
doi: 10.1007/s12149-016-1062-2 |
[8] |
Eguchi T, Yoshida K, Hamanaka K, et al.
Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours[J]. Eur J Cardiothorac SurgEur J Cardiothorac Surg, 2012, 41(5): 1059-1062.
doi: 10.1093/ejcts/ezr144 |
[9] |
Fukumoto K, Taniguchi T, Ishikawa Y, et al.
The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours[J]. Eur J Cardiothorac SurgEur J Cardiothorac Surg, 2012, 42(6): e152-e156.
doi: 10.1093/ejcts/ezs527 |
[10] |
Park SY, Cho A, Bae MK, et al.
Value of 18F-FDG PET/CT for predicting the World Health Organization malignant grade of thymic epithelial tumors: focused in volume-dependent parameters[J]. Clin Nucl MedClin Nucl Med, 2016, 41(1): 15-20.
doi: 10.1097/RLU.0000000000001032 |
[11] |
Gong J, Jin S, Pan X, et al.
Identification of long non-coding RNAs for predicting prognosis among patients with thymoma[J]. Clin LabClin Lab, 2018, 64(7): 1193-1198.
doi: 10.7754/Clin.Lab.2018.180136 |
[12] |
Tomita M, Ayabe T, Tsuchiya K, et al.
Fluorodeoxyglucose positron emission tomography can provide useful information for differentiating thymic epithelial tumors[J]. Thorac Cardiovasc SurgThorac Cardiovasc Surg, 2018, 66(4): 345-349.
doi: 10.1055/s-0037-1604208 |